Phaarmasia Ltd Share Price

Phaarmasia
Small Cap | Pharmaceuticals
₹ 88.08 4.19 (4.99%)
Last updated: 09-Dec-2025 , 16:01:50

Phaarmasia Ltd Live Price Chart

Low: ₹88.08 High: 88.08

Phaarmasia Ltd Technicals

Current Price
₹ 88.08 4.19 (4.99%)
EMASMA
20 Day ₹ 59.139
50 Day ₹ 47.190
100 Day ₹ 41.262
200 Day ₹ 38.861
20 Day ₹ 54.190
50 Day ₹ 42.326
100 Day ₹ 37.711
200 Day ₹ 35.195

Phaarmasia Ltd Performance

Previous Close ₹ 83.89
High ₹ 88.08
Volume 6592
52W Range ₹ 23.6 - ₹ 83.89
Open ₹ 88.08
Low ₹ 88.08
Market Cap 42.77 Cr

Phaarmasia Ltd Fundamentals

ROCE 7.840
P/E Ratio 73.590
P/B Ratio 8.810
Industry P/E 8.810
Debt to Equity 39.786
ROE 7.277
EPS 1.140
Dividend Yield 0.000
Book Value 9.523
Face Value 10.000

Phaarmasia Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 25.1151 31.2548 28.0056 17.6855 20.7888091
Total Expenses 26.7178 31.8007 29.4376 19.2477 20.3100981
Profit After Tax -1.5894 -0.5182 -1.2592 -1.5472 0.3119863

Phaarmasia Ltd Shareholding Pattern

Promoter Holdings 73.513 %
FIIs 0.000 %
DIIs 0.058 %
MutualFund 0.000 %
Retail 25.817 %
Others - 0.612 %

About Phaarmasia Ltd

History of Phaarmasia Ltd

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Cipla Ltd ₹ 1335 - ₹ 1673 1490.7 22.25
J B Chemicals & Pharmaceuticals Ltd ₹ 1385.75 - ₹ 1952 1797.9 40.16
Unichem Laboratories Ltd ₹ 440 - ₹ 836.4 446.9 54.89
Lyka Labs Ltd ₹ 73.95 - ₹ 176.59 78 225.48
Dr Reddys Laboratories Ltd ₹ 1020 - ₹ 1405.9 1248.4 19.59

FAQs on Phaarmasia Ltd

1. Can I buy Phaarmasia Ltd from PL Capital? ›

Yes, you can invest in Phaarmasia Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Phaarmasia Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Phaarmasia Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Phaarmasia Ltd pay dividends? ›

Phaarmasia Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Phaarmasia Ltd ? ›

As of 08-12-2025 the share price for Phaarmasia Ltd. is 83.89 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Phaarmasia Ltd ? ›

The 52-week high and low of Phaarmasia Ltd share price is ₹ 23.6 - ₹ 83.89 as of 08-12-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source